This experiment was conducted to investigate growth performance, carcass traits and meat quality of finishing pigs with dietary β-glucan supplementation. A total of 96 healthy pigs (Duroc × Landrace × Yorkshire; initial average BW = 25 kg) were randomly allocated into 4 dietary treatments with 6 replicates per treatment and 4 pigs per replicate. The control group was fed a basal diet, and the experimental diets were supplemented with 50, 100 and 200 mg/kg Agrobacterium sp. ZX09 β-glucan, respectively. The experiment lasted 103 d. The basal diet supplemented with 100 mg/kg β-glucan significantly increased average daily gain and feed conversion ratio, probably due to the improved digestibility of dry matter, gross energy and crude protein (P < 0.05). Beta-glucan supplementation from 100 to 200 mg/kg of diet significantly increased carcass length (P < 0.05). The basal diet supplemented with 100 mg/kg β-glucan supplementation also significantly (P < 0.05) increased muscle pH, reduced drip losses and increased a∗ values. The basal diet supplemented with 100 mg/kg β-glucan increased the content of intramuscular fat and changed the proportion of saturated fatty acid and unsaturated fatty acid, thereby improved the flavor of meat. In conclusion, the basal diet supplemented with 100 mg/kg Agrobacterium sp. ZX09 β-glucan improves growth performance, nutrient digestibility, carcass length, and pork quality of finishing pigs.
Simple SummaryBeta-glucan is currently under consideration as an alternative to in-feed antibiotics for the sustainable pig production industry in China. Modulating intestinal function by β-glucan treatment in young pigs is one potential way of decreasing disease susceptibility and presumably increasing growth performance. In the present study, as a newly developed commercial product, β-glucans have proved to modulate gut function, and have improved growth performance in lipopolysaccharide (LPS)-challenged piglets. The present study aimed to determine the mechanisms involved inβ-glucan of low and high molecular weight mediated growth alterations in weaned piglets. The results confirmed that β-glucans isolated from Agrobacterium sp. ZX09 could improve growth performance in weaned piglets and they showed intestinal modulatory properties via different mechanisms in regulating the mucosal barrier function and microbial populations between two different molecular weight β-glucans.AbstractThis study investigated β-glucan derived from Agrobacterium sp. ZX09 with high (2000 kDa) and low (300 kDa) molecular weight (MW) to compare their effects on growth performance and gut function in LPS-induced weaned piglets. Changes in jejunal morphology, mucosal barrier function, microbial populations, and fermentation in the piglets were determined. Data showed that β-glucan prevented body weight loss in LPS challenged piglets. Supplementation with both β-glucan fractions improved jejunal morphology. Compared to low MW, β-glucan of high MW generally up-regulated transcripts of ZO-1, MUC1, and MUC2 in jejunal mucosa to a lesser extent. Mucosal D-lactate, diamine oxidase, and anti-oxidation index were effectively resumed in β-glucan treatment. Both β-glucan diets provoked the emergence of a balanced microbiota and a richer concentration of volatile fatty acids in the colon. The richest community of bifidobacterium and concentration of butyrate emerged after feeding β-glucan with high MW. Results suggested that the effect of Agrobacterium sp. ZX09 β-glucans on the gut-modulatory function is largely linked to their MW. Low MW β-glucan mainly improved the mucosal barrier function in the jejunum, while high MW β-glucan had profound effects on the microbial community and fermentation in the hindgut of piglets.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2025 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.